20 May Opinion: The 340B drug-pricing program, a critical MetroHealth patient lifeline, is under threat

“This spring, I find myself embracing the change of season and reflecting on the challenges of seasons past. For two years, we intensive-care professionals have cared for critically ill COVID-19 patients with ravaged lungs who clung for life on ventilators. We witnessed tragic and heartbreaking deaths. Patients who survived still endure a long road to full recovery. Through all the challenges, I was grateful our health system had the resources we needed to provide exceptional care to the critically ill.

But now, one crucial resource is under significant threat, and I worry what will happen during the next major public health emergency.”

Read more: https://www.cleveland.com/opinion/2022/05/the-340b-drug-pricing-program-a-critical-metrohealth-patient-lifeline-is-under-threat-sherrie-d-williams.html